Evidence-based Laboratory Medicine Practice Guidelines

ASM develops Evidence-based Laboratory Medicine Practice Guidelines (EBLMPG) that address laboratory quality issues, pre- or post-analytic, that need improvement. ASM adheres to the CDC’s A-6 methodology. This methodology is transparent, objective, and rigorous to provide evidence-based information to healthcare stakeholders about the effectiveness of quality improvement practices.

Currently, three guidelines are under development:

  1. "What practices are effective at increasing timeliness for providing targeted therapy for those patients who are admitted for or are found to have bloodstream infections (e.g., positive blood cultures to) to improve clinical outcomes (LOS, antibiotic costs, morbidity, mortality)?"

  2. “Does optimizing the collection, preservation and transport of urine for microbiological culture improve the diagnosis and management of patients with urinary tract infections?"

  3. C. difficile,  "Among hospital inpatients, what diagnostic testing strategies are the most effective in leading to improved clinical, organization, and economic outcomes?”

  4. Antimicrobial Resistance. This guideline question is under development. 

ASM would like to hear your ideas for the additional topics. Specifically, what laboratory practices need improvement? What are the laboratory quality gaps? Submit your topic(s) by completing this form. Email your completed form to professionalpractice@asmusa.org.